Device Trial Radar · NCT04430075
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Aug 23, 2019
Primary completion
Sep 4, 2025
Study completion Mar 31, 2031
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- First posted
- Jun 12, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter mitral valve repair.
Conditions
- Mitral Regurgitation
- Mitral Insufficiency
Interventions
Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair SystemDevice
Transcatheter Valve Repair with Edwards PASCAL and PASCAL Precision System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of patients with major adverse events (MAE rates)Time frame: 30 days
- Change in mitral regurgitation severity (scale of 0-4+) by echocardiographyTime frame: Discharge: defined as discharge or 7 days post-procedure, whichever comes first
Locations
37 sites in 9 countries. Site status is shown where the registry gives one.
Medizinische Universität Wien/AKH Wien
Vienna, Austria
Zentralklinik Bad Berka GmbH
Bad Berka, Germany
Charité Berlin
Berlin, Germany
34 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.